AP NEWS

BIOLASE® to Host 2018 Second Quarter Financial Results Conference Call on August 8, 2018

August 1, 2018

IRVINE, Calif.--(BUSINESS WIRE)--Aug 1, 2018--BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, August 8, 2018, at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2018, and to answer questions. A press release disclosing the Company’s financial results will be distributed at approximately 8:30 a.m. Eastern Time that same day.

Phone Participation To listen to the conference call live via telephone, dial 877-407-4019 from the U.S. or, for international callers, dial 1-201-689-8337, approximately 10 minutes before the start time.

Webcast Participation To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at www.biolase.com.

Replay An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 220 patented and 95 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE’s innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 36,200 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase® iPlus™, Waterlase Express™, and laser dentistry, find BIOLASE online at  www.biolase.com, Facebook at  www.facebook.com/biolase, Twitter at  www.twitter.com/biolaseinc  and LinkedIn at  www.linkedin.com/company/biolase.

BIOLASE ®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180801005325/en/

CONTACT: DresnerAllenCaron

Rene Caron (Investors)

Office: 949-474-4300

Mobile: 949-813-6945

rcaron@dresnerallencaron.com

or

Len Hall (Financial Media)

949-474-4300

lhall@dresnerallencaron.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH DENTAL MEDICAL DEVICES

SOURCE: BIOLASE, Inc.

Copyright Business Wire 2018.

PUB: 08/01/2018 08:30 AM/DISC: 08/01/2018 08:30 AM

http://www.businesswire.com/news/home/20180801005325/en

AP RADIO
Update hourly